Highlights and Quick Summary
- Common Equity (Total) for the quarter ending March 31, 2023 was $184 Million (a 45.84% increase compared to previous quarter)
- Year-over-year quarterly Common Equity (Total) increased by 230.86%
- Annual Common Equity (Total) for 2022 was $126 Million (a 17.62% increase from previous year)
- Annual Common Equity (Total) for 2021 was $107 Million (a 59.81% increase from previous year)
- Annual Common Equity (Total) for 2020 was $67.2 Million (a -6.33% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Equity (Total) of Precigen, Inc.
Most recent Common Equity (Total)of PGEN including historical data for past 10 years.Interactive Chart of Common Equity (Total) of Precigen, Inc.
Precigen, Inc. Common Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $184.13 | – | – | – | – |
| 2022 | $126.26 | $142.53 | $55.65 | $73.84 | $126.26 |
| 2021 | $107.35 | $131.25 | $159.2 | $174.8 | $107.35 |
| 2020 | $67.17 | $58.55 | $49.54 | $87.23 | $67.17 |
| 2019 | $71.71 | $228.42 | $279.22 | $334.82 | $71.71 |
| 2018 | $378.72 | $555.44 | $567.14 | $634.12 | $378.72 |
| 2017 | $546.55 | $553.18 | $571.55 | $550.16 | $546.55 |
| 2016 | $569.25 | $608.42 | $628.18 | $674.83 | $569.25 |
| 2015 | $704.89 | $729.62 | $486.93 | $653.34 | $704.89 |
| 2014 | $409.29 | $379.84 | $388.37 | $431.9 | $409.29 |
| 2013 | – | $381.34 | $391.21 | $-361.52 | $381.34 |
| 2012 | – | – | – | – | $-321.55 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology